Drug Shortage Report for ADVAIR 125

Last updated on 2022-01-19 History
Report ID 151138
Drug Identification Number 02245126
Brand name ADVAIR 125
Common or Proper name fluticasone propionate and salmeterol pressurized inhalation, suspension
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) FLUTICASONE PROPIONATE SALMETEROL
Strength(s) 125MCG 25MCG
Dosage form(s) AEROSOL, METERED DOSE
Route of administration INHALATION INHALATION
Packaging size 1x120
ATC code R03AK
ATC description ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-12-09
Estimated end date 2022-01-19
Actual end date 2022-01-18
Shortage status Resolved
Updated date 2022-01-19
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-12-14 English Compare
v2 2021-12-14 French Compare
v3 2022-01-19 English Compare
v4 2022-01-19 French Compare

Showing 1 to 4 of 4